Merck & Co., Inc. (MRK) stock
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30106% above fair value
$146.95−0.23 (-0.16%)
Close on Nov 12, 2026Market cap $362.55BP/E 151.5Yield 2.23%
Merck gross margin
Gross margin is gross profit as a percentage of revenue.
Merck's gross margin for the twelve months ending Sep 30, 2026 was 71.8%. For fiscal 2025 it was 74.8%, against 76.3% the year before. The highest annual figure on record is 76.6% in fiscal 2008.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 74.8% | −1.5 |
| FY2024 | Dec 31, 2024 | 76.3% | +3.1 |
| FY2023 | Dec 31, 2023 | 73.2% | +2.5 |
| FY2022 | Dec 31, 2022 | 70.6% | −1.4 |
| FY2021 | Dec 31, 2021 | 72.0% | +4.8 |
| FY2020 | Dec 31, 2020 | 67.2% | −2.1 |
| FY2019 | Dec 31, 2019 | 69.3% | +1.2 |
| FY2018 | Dec 31, 2018 | 68.1% | +0.2 |
| FY2017 | Dec 31, 2017 | 67.8% | +3.1 |
| FY2016 | Dec 31, 2016 | 64.8% | +2.6 |
| FY2015 | Dec 31, 2015 | 62.2% | +1.9 |
| FY2014 | Dec 31, 2014 | 60.3% | −1.2 |
| FY2013 | Dec 31, 2013 | 61.5% | −3.7 |
| FY2012 | Dec 31, 2012 | 65.2% | +0.3 |
| FY2011 | Dec 31, 2011 | 64.9% | +4.9 |
| FY2010 | Dec 31, 2010 | 60.0% | −7.1 |
| FY2009 | Dec 31, 2009 | 67.1% | −9.5 |
| FY2008 | Dec 31, 2008 | 76.6% | +2.0 |
| FY2007 | Dec 31, 2007 | 74.6% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 72.9% | −4.7 |
| Q2 FY2026 | Jun 30, 2026 | 73.5% | −4.0 |
| Q1 FY2026 | Mar 31, 2026 | 74.2% | −3.7 |
| Q4 FY2025 | Dec 31, 2025 | 66.2% | −9.3 |
| Q3 FY2025 | Sep 30, 2025 | 77.7% | +2.2 |
| Q2 FY2025 | Jun 30, 2025 | 77.5% | +0.7 |
| Q1 FY2025 | Mar 31, 2025 | 78.0% | +0.4 |
| Q4 FY2024 | Dec 31, 2024 | 75.5% | +2.2 |
| Q3 FY2024 | Sep 30, 2024 | 75.5% | +2.2 |
| Q2 FY2024 | Jun 30, 2024 | 76.8% | +3.5 |
| Q1 FY2024 | Mar 31, 2024 | 77.6% | +4.7 |
| Q4 FY2023 | Dec 31, 2023 | 73.3% | +1.3 |
| Q3 FY2023 | Sep 30, 2023 | 73.3% | −0.4 |
| Q2 FY2023 | Jun 30, 2023 | 73.2% | +2.1 |
| Q1 FY2023 | Mar 31, 2023 | 72.9% | +6.7 |
| Q4 FY2022 | Dec 31, 2022 | 71.9% | +0.6 |
| Q3 FY2022 | Sep 30, 2022 | 73.7% | −0.1 |
| Q2 FY2022 | Jun 30, 2022 | 71.1% | −1.7 |
| Q1 FY2022 | Mar 31, 2022 | 66.2% | −3.7 |
| Q4 FY2021 | Dec 31, 2021 | 71.3% | +17.3 |
| Q3 FY2021 | Sep 30, 2021 | 73.8% | +1.3 |
| Q2 FY2021 | Jun 30, 2021 | 72.8% | +2.1 |
| Q1 FY2021 | Mar 31, 2021 | 69.9% | −2.6 |
| Q4 FY2020 | Dec 31, 2020 | 54.1% | −8.0 |
| Q3 FY2020 | Sep 30, 2020 | 72.4% | +4.6 |
| Q2 FY2020 | Jun 30, 2020 | 70.6% | −0.5 |
| Q1 FY2020 | Mar 31, 2020 | 72.5% | +0.7 |
| Q4 FY2019 | Dec 31, 2019 | 62.1% | −8.0 |
| Q3 FY2019 | Sep 30, 2019 | 67.8% | +1.3 |
| Q2 FY2019 | Jun 30, 2019 | 71.1% | +3.7 |
| Q1 FY2019 | Mar 31, 2019 | 71.8% | +3.5 |
| Q4 FY2018 | Dec 31, 2018 | 70.1% | +3.1 |
| Q3 FY2018 | Sep 30, 2018 | 66.5% | −1.5 |
| Q2 FY2018 | Jun 30, 2018 | 67.3% | −1.3 |
| Q1 FY2018 | Mar 31, 2018 | 68.3% | +0.6 |
| Q4 FY2017 | Dec 31, 2017 | 67.0% | +1.3 |
| Q3 FY2017 | Sep 30, 2017 | 68.0% | – |
| Q2 FY2017 | Jun 30, 2017 | 68.6% | – |
| Q1 FY2017 | Mar 31, 2017 | 67.7% | – |
| Q4 FY2016 | Dec 31, 2016 | 65.7% | – |
See a number that looks wrong?